{"count": 1, "results": [{"_id": "34311050", "pmid": 34311050, "title": "Metformin attenuates vascular pathology by increasing expression of insulin-degrading enzyme in a mixed model of cerebral amyloid angiopathy and type 2 diabetes mellitus.", "journal": "Neurosci Lett", "authors": ["Inoue Y", "Masuda T", "Misumi Y", "Ando Y", "Ueda M"], "date": "2021-09-25T00:00:00Z", "doi": "10.1016/j.neulet.2021.136136", "meta_date_publication": "2021 Sep 25", "meta_volume": "762", "meta_issue": "", "meta_pages": "136136", "score": 50265.27, "text_hl": "However, the therapeutic effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Cerebral_Amyloid_Angiopathy</m> @DISEASE_MESH:D016657 @@@CAA@@@ are unclear. ", "citations": {"NLM": "Inoue Y, Masuda T, Misumi Y, Ando Y, Ueda M. Metformin attenuates vascular pathology by increasing expression of insulin-degrading enzyme in a mixed model of cerebral amyloid angiopathy and type 2 diabetes mellitus. Neurosci Lett. 2021 Sep 25;762():136136. PMID: 34311050", "BibTeX": "@article{34311050, title={Metformin attenuates vascular pathology by increasing expression of insulin-degrading enzyme in a mixed model of cerebral amyloid angiopathy and type 2 diabetes mellitus.}, author={Inoue Y and Masuda T and Misumi Y and Ando Y and Ueda M}, journal={Neurosci Lett}, volume={762}, pages={136136}}"}}]}